Maternal hypoxia during pregnancy induces fetal neurodevelopmental brain damage: Partial protection by magnesium sulfate

Journal of Neuroscience Research

Volumn 78, Issue 3, 2004, Pages 430-441

  Golan, Hava ^a   Kashtuzki, I ^a   Hallak, M ^a   Sorokin, Y ^b   Huleihel, M ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b HUTZEL HOSPITAL   (United States)

Author keywords

Hypoxia; Magnesium sulfate; Neurogenesis; Neurotrophic factors

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; MAGNESIUM SULFATE; NERVE GROWTH FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN INJURY; BRAIN OXYGEN CONSUMPTION; CELL DENSITY; CELL SIZE; CEREBELLUM; CEREBRAL PALSY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MODEL; FEMALE; FETUS; FETUS HYPOXIA; HIPPOCAMPUS; HISTOPATHOLOGY; LEUKOMALACIA; LONG TERM MEMORY; MOTOR DYSFUNCTION; MOUSE; NEUROPROTECTION; NEWBORN; NONHUMAN; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PROTEIN STABILITY; PURKINJE CELL; RISK ASSESSMENT; SHORT TERM MEMORY;

AGE FACTORS; ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; ANOXIA; ANTICONVULSANTS; ATAXIA; BEHAVIOR, ANIMAL; BRAIN; BRAIN INJURIES; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL COUNT; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; MAGNESIUM SULFATE; MALE; MAZE LEARNING; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; NERVE GROWTH FACTOR; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PSYCHOMOTOR PERFORMANCE; SPATIAL BEHAVIOR;

EID: 8444230560     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.20269     Document Type: Article

References (51)

1. Almli CR, Levy TJ, Han HB, Shan AR, Gidday JM, Holzman DM. 2000. BDNF protects against spatial memory deficits following neonatal hypoxia-ischemia. Exp Neurol 166:99-114.
2. Altman J, Bayer SA. 1990. Prolonged sojourn of developing pyramidal cells in the intermediate zone of the hippocampus and their settling in the stratum pyramidale. J Comp Neurol 301:343-364.
3. Bayer SA. 1980a. Development of the hippocampal region in the rat. I. Neurogenesis examined with [3H] thymidine autoradiography. J Comp Neurol 416:303-325.
4. Bayer SA. 1980b. Development of the hippocampal region in the rat. II. Morphogenesis during embryonic and early prenatal life. J Comp Neurol 190:115-134.
5. Bibel M, Barde YA, McAllister AK. 2000. Neurotrophins: key regulators of cell fate and cell shape in the vertebrate nervous system. Genes Dev 14:2919-2937.
6. Cai Z, Xiao F, Lee B, Paul IA, Rhodes PG. 1999. Prenatal hypoxia-ischemia alters expression and activity of nitric oxide synthase in the young rat brain and causes learning deficits. Brain Res Bull 49:359-365.
7. Cheng Y, Gidday JM, Yan Q, Shah AR, Holtzman DM. 1997. Marked age-dependent neuroprotection by brain-derived neurotrophic factor against neonatal hypoxic-ischemic brain injury. Ann Neurol 41:521-529.
8. Cline HT, Constantine-Paton M. 1989. NMDA receptor antagonists disrupt the retinocortical topographic map. Neuron 3:413-426.
9. Crawley JN. 1999. What's wrong with my mouse? Behavioral phenotyping of transgenic and knockout mice. New York: Wiley-Liss. p 39-41.
10. D'Hooge R, De Deyn PP. 2001. Applications of the Morris water maze in the study of learning and memory. Brain Res Brain Res Rev 36:60-90.
11. Golan H, Kashtutsky I, Hallak M, Sorokin Y, Huleihel M. 2004. Maternal hypoxia during pregnancy delayed the development of motor reflex in newborn mice. Dev Neurosci (in press).
12. Gould E, Tanapa P, McEwen BS, Flagge G, Fuchs E. 1998. Proliferation of granule cell precursors in the dentate gyrus of adult monkeys is diminished by stress. Proc Natl Acad Sci USA 95:3168-3171.
13. Grojean S, Pouri G, Vert P, Daval JL. 2003. Differential neuronal fates in the CA1 hippocampus after hypoxia in newborn and 7-day-old rats: effects of pretreatment with MK-801. Hippocampus 13:970-977.
14. Hallak M, Hotra JW, Kupsky W. 2000. Magnesium sulfate protection of fetal rat brain from severe maternal hypoxia. Obstet Gynecol 96:124-128.
15. Huarg E, Reichardt L. 2001. Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci 24:1217-1281.
16. Katz A, Kerem D, Sherman D. 1990. Magnesium sulfate suppresses electroencephalographic manifestations of CNS oxygen toxicity. Undersea Biomed Res 17:45-49.
17. Katz LC, Shatz CJ. 1996. Synaptic activity and the construction of cortical circuits. Science 274:1133-1138.
18. Kleckner NW, Dingledine R. 1991. Regulation of hippocampal NMDA receptors by magnesium and glycine during development. Brain Res Mol Brain Res 11:151-159.
19. Kleinschmidt A, Bear MF, Singer W. 1987. Blockade of "NMDA" receptors disrupts experience-dependent plasticity of kitten striate cortex. Science 238:355-358.
20. Kuner T, Schoepfer R. 1996. Multiple structural elements determine subunit specificity of Mg2+ block in NMDA receptor channels. J Neurosci 16:3549-3558.
21. Lee C, Kim DW, Jeon GS, Roh EJ, Seo JH, Wang KC, Cho SS. 2001. Cerebellar alterations induced by chronic hypoxia: an immunohistochemical study using a chick embryonic model. Brain Res 901:271-276.
22. Lipton SA, Rosenberg PA. 1994. Excitatory amino acids as a final common pathway for neurologic disorders. N Engl J Med 330:613-622.
23. McAllister AK, Katz LC, Lo DC. 1995. Neurotrophins regulate dendritic growth in developing visual cortex. Neuron 15:791-803.
24. McAllister AK, Katz LC, Lo DC. 1997. Opposing roles for endogenous BDNF and NT-3 in regulating cortical dendritic growth. Neuron 18:767-778.
25. McDonald JW, Silverstein FS, Johnston MV. 1988. Neurotoxicity of N-methyl-D-aspartate is markedly enhanced in developing rat central nervous system. Brain Res 459:200-203.
26. McDonald JW, Silverstein FS, Johnston MV. 1990. Magnesium reduces N-methyl-D-aspartate (NMDA)-mediated brain injury in perinatal rats. Neurosci Lett 109:234-238.
27. McQuillen PS, Sheldon RA, Shatz CJ, Ferriero DM. 2003. Selective vulnerability of subplate neurons after early neonatal hypoxia-ischemia. J Neurosci 23:3308-3315.
28. Mertz K, Koscheck T, Schilling K. 2000. Brain-derived neurotrophic factor modulates dendritic morphology of cerebellar basket and stellate cells: an in vitro study. Neuroscience 97:303-310.
29. Messesmith EK, Feller MB, Zhang H, Shatz CJ. 1997. Migration of neocortical neurons in the absence of functional NMDA receptors. Mol Cell Neurosci 9:347-357.
30. Monaghan DT, Bridges RJ, Cotman CW. 1989. The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system. Annu Rev Pharmacol Toxicol 29:365-402.
31. Monyer H, Burnashev N, Laurie D, Sakmann B, Seeburg PH. 1994. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 12:529-540.
32. Monyer H, Sprengel R, Schoepfer R, Herb A, Higuchi M, Lomeli H, Burnashev N, Sakmann B, Seeburg PH. 1992. Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science 256:1217-1221.
33. Morris R. 1984. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 11:47-60.
34. Nelson KB, Grether JK. 1995. Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants? Pediatrics 95:263-269.
35. Schendel DE, Berg CJ, Yeargin-Allsopp M, Boyle CA, Decoufle P. 1996. Prenatal magnesium sulfate exposure and the risk for cerebral palsy or mental retardation among very low-birth-weight children aged 3 to 5 years. JAMA 276:1805-1810.
36. Scheetz AJ, Nairn AC, Constantine-Paton M. 2000. NMDA receptor-mediated control of protein synthesis at developing synapses. Nat Neurosci 3:211-216.
37. Schmidt-Kastner R, Zhang B, Belayev L, Khoutorova L, Amin R, Busto R, Ginsberg MD. 2002. DNA microarray analysis of cortical gene expression during early recirculation after focal brain ischemia in rat. Brain Res Mol Brain Res 108:81-93.
38. Segal RA, Takahashi H, McKay RD. 1992. Changes in neurotrophin responsiveness during the development of cerebellar granule neurons. Neuron 9:1041-1052.
39. Sherrard RM, Bower AJ. 2002. Climbing fiber development: do neurotrophins have a part to play? Cerebellum 1:265-275.
40. Simon DK, Prusky GT, O'Leary DDM, Constantine-Paton M. 1992. NMDA receptor antagonists disrupt the formation of a mammalian neural map. Proc Natl Acad Sci USA 89:10593-10597.
41. Simonova Z, Sterbova K, Brozek G, Komarek V, Sykova E. 2003. Postnatal hypobaric hypoxia in rats impairs water maze learning and the morphology of neurons and macroglia in cortex and hippocampus. Behav Brain Res 141:195-205.
42. Sombati S, Coulter DA, DeLorenzo RJ. 1991. Neurotoxic activation of glutamate receptors induces an extended neuronal depolarization in cultured hippocampal neurons. Brain Res 566:316-319.
43. Sofroniew M, Howe C, Mobley W. 2001. Nerve growth factor signaling, neuroprotection, and neural repair. Annu Rev Neurosci 24:677-736.
44. Sorra KE, Harris KM. 2000. Overview on the structure, composition, function, development, and plasticity of hippocampal dendritic spines. Hippocampus 10:501-511.
45. Tsuda T, Kogure K, Nishioka K, Watanabe T. 1991. Mg2+ administered up to twenty-four hours following reperfusion prevents ischemic damage of the CA1 neurons in the rat hippocampus. Neuroscience 44:335-341.
46. Tyzio R, Represa A, Jorquera I, Ben-Ari Y, Gozlan H, Aniksztejn L. 1999. The establishment of GABAergic and glutamatergic synapses on CA1 pyramidal neurons is sequential and correlates with the development of the apical dendrite. J Neurosci 19:10372-10382.
47. Van Praagh H, Schinder AF, Christie BR, Toni N, Palmer TD, Gage FH. 2002. Functional neurogenesis in the adult hippocampus. Nature 415:1030-1034.
48. Volpe JJ. 1995. Hypoxic-ischemic encephalopathy. In: Volpe JJ, editor. Neurology of the newborn. Third ed. Philadelphia: W.B. Saunders Co. p 211-369.
49. Volpe JJ. 2001. Neurobiology of periventricular leukomalacia in the pre-mature infant. Pediatr Res 50:553-562.
50. Wernig A. 1972. The effects of calcium and magnesium on statistical release parameters at the crayfish neuromuscular junction. J Physiol 226:761-768.
51. Wolf G, Keilhoff G, Fisher S, Hass P. 1990. Subcataneously applied magnesium protects reliably against quinolinate-induced N-methyl-D-aspartate (NMDA)-mediated neurodegeneration and convulsions in rats: are there therapeutic implications? Neurosci Lett 117:207-211.